Your browser doesn't support javascript.
loading
Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.
Timmermans, Adriana J; Lange, Charlotte A H; de Bois, Josien A; van Werkhoven, Erik; Hamming-Vrieze, Olga; Hilgers, Frans J M; van den Brekel, Michiel W M.
Afiliação
  • Timmermans AJ; Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lange CA; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Bois JA; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hamming-Vrieze O; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hilgers FJ; Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van den Brekel MW; Institute of Phonetic Sciences/Amsterdam Center for Language and Communication, University of Amsterdam, Amsterdam, the Netherlands.
Laryngoscope ; 126(2): E60-7, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26333005
ABSTRACT
OBJECTIVES/

HYPOTHESIS:

Tumor volume has been postulated to be an important prognostic factor for oncological outcome after radiotherapy or chemoradiotherapy. This postulate was retrospectively investigated in a consecutively treated cohort of T3-T4 larynx cancer patients. STUDY

DESIGN:

Retrospective cohort study.

METHODS:

For 166 patients with T3-T4 larynx cancer (1999-2008), pretreatment computed tomography and magnetic resonance imaging scans were available for tumor volume delineation. Patients were treated with radiotherapy, chemoradiotherapy, or total laryngectomy with postoperative radiotherapy. Both a dedicated head and neck radiologist and the first author determined all tumor volumes. Statistical analysis was by Kaplan-Meier plots and Cox proportional hazard models.

RESULTS:

Patients with T3 larynx cancer had significantly smaller tumor volumes than patients with T4 larynx cancer (median = 8.1 cm(3) and 15.8 cm(3), respectively; P < .0001). In the group treated with total laryngectomy and postoperative radiotherapy, no association was found between tumor volume and local or locoregional control or overall survival. In the group treated with radiotherapy, a nonsignificant trend was observed between local control and tumor volume. In the chemoradiotherapy group, however, a significant impact of tumor volume was found on local control (hazard ratio = 1.07; 95% confidence interval = 1.01-1.13; P = .028).

CONCLUSIONS:

Tumor volume was not significantly associated with local control, locoregional control, or overall survival in the surgically treated group. In the group treated with radiotherapy, there was no statistically significant association, but a trend was observed between local control and tumor volume. Only in patients treated with concurrent chemoradiotherapy was a significant impact of tumor volume on local control found. LEVEL OF EVIDENCE 4.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Laríngeas / Carga Tumoral / Estadiamento de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Laríngeas / Carga Tumoral / Estadiamento de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article